Exhibit 4.4 THIS WARRANT HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "1933 ACT"), OR ANY APPLICABLE STATE SECURITIES LAWS. AND MAY NOT BE SOLD OR TRANSFERRED UNLESS SUCH SALE OR TRANSFER IS IN ACCORDANCE WITH THE...Rigel Pharmaceuticals Inc • September 15th, 2000 • Services-commercial physical & biological research • California
RECITALSLicense Agreement • September 15th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • California
Exhibit 4.2 RIGEL PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT TABLE OF CONTENTSRights Agreement • September 15th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • California
4. NET ISSUE ELECTION. The Holder may elect to receive, without the payment by the Holder of any additional consideration, shares of Preferred Stock equal to the value of this Warrant or any portion hereof by the surrender of this Warrant or such...Rigel Pharmaceuticals Inc • September 15th, 2000 • Services-commercial physical & biological research • California
Exhibit 1.1 9,000,000 SHARES RIGEL PHARMACEUTICALS, INC. COMMON STOCK ($0.001 PAR VALUE) UNDERWRITING AGREEMENTRigel Pharmaceuticals Inc • October 16th, 2000 • Services-commercial physical & biological research • New York
16,000,000 Shares Rigel Pharmaceuticals, Inc. UNDERWRITING AGREEMENTUnderwriting Agreement • April 20th, 2018 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
Exhibit 1.1 UNDERWRITING AGREEMENTUnderwriting Agreement • March 28th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • New York
RECITALSIndemnity Agreement • September 15th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
Rigel Pharmaceuticals, Inc., Issuer AND [TRUSTEE], TrusteeIndenture • February 26th, 2009 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
INDENTURE, dated as of [·], 200 , among RIGEL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
·], AS WARRANT AGENTWarrant Agreement • March 9th, 2018 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [·], between RIGEL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and [·], a [corporation] [national banking association] organized and existing under the laws of [·] and having a corporate trust office in [·], as warrant agent (the “Warrant Agent”).
RIGEL PHARMACEUTICALS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementSales Agreement • August 18th, 2015 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
Rigel Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
RIGEL PHARMACEUTICALS, INC., Issuer AND [TRUSTEE], TrusteeRigel Pharmaceuticals Inc • March 9th, 2018 • Pharmaceutical preparations • New York
INDENTURE, dated as of [·], 20[·], among RIGEL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [TRUSTEE], as trustee (the “Trustee”):
RIGEL PHARMACEUTICALS, INC. AND , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OF [ ], 20 RIGEL PHARMACEUTICALS, INC. FORM OF COMMON STOCK WARRANT AGREEMENTCommon Stock Warrant Agreement • May 7th, 2015 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between RIGEL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
·], AS WARRANT AGENTWarrant Agreement • March 9th, 2018 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
This DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between RIGEL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
OPEN MARKET SALE AGREEMENTSMRigel Pharmaceuticals Inc • August 4th, 2020 • Pharmaceutical preparations • New York
Rigel Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell from time to time through Jefferies LLC, as sales agent and/or principal (the “Agent”), shares of the Company’s common stock, par value $0.001 per share (the “Common Shares”), on the terms set forth in this agreement (this “Agreement”).
RIGEL PHARMACEUTICALS, INC. AND , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OF [ ], 20 RIGEL PHARMACEUTICALS, INC. FORM OF PREFERRED STOCK WARRANT AGREEMENTPreferred Stock Warrant Agreement • May 7th, 2015 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of between RIGEL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
RECITALSLicense Agreement • March 28th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • California
RECITALSCollaboration Agreement • September 15th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • Delaware
13,685,000 Shares Rigel Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 3rd, 2012 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
INDEMNITY AGREEMENTIndemnity Agreement • May 10th, 2007 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS INDEMNITY AGREEMENT (this “Agreement”) dated as of __________ ___, 200__, is made by and between Rigel Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and _______________ (“Indemnitee”).
RIGEL PHARMACEUTICALS, INC. and , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFDebt Securities Warrant Agreement • February 26th, 2009 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between RIGEL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
RIGEL PHARMACEUTICALS, INC. AND , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OF [ ], 20 RIGEL PHARMACEUTICALS, INC. FORM OF DEBT SECURITIES WARRANT AGREEMENTSecurities Warrant Agreement • May 7th, 2015 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of between RIGEL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
ARTICLE 1 DEFINITIONSTechnology Transfer Agreement • November 17th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • California
EXHIBIT 10.7 COLLABORATIVE RESEARCH AND LICENSE AGREEMENT THIS COLLABORATIVE RESEARCH AND LICENSE AGREEMENT ("the Agreement") is entered into as of January 31, 1999 ("Effective Date") by and between PFIZER INC, a Delaware corporation, having an office...Collaborative Research and License Agreement • September 15th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • New York
4. NET ISSUE ELECTION. The Holder may elect to receive, without the payment by the Holder of any additional consideration, shares of Preferred Stock equal to the value of this Warrant or any portion hereof by the surrender of this Warrant or such...Rigel Pharmaceuticals Inc • February 4th, 2000 • California
CREDIT AND SECURITY AGREEMENT dated as of September 27, 2019 by and among RIGEL PHARMACEUTICALS, INC., as a Borrower and any additional borrower that hereafter becomes party hereto, and MIDCAP FINANCIAL TRUST, as Agent and as a Lender, and THE...Credit and Security Agreement • November 5th, 2019 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS CREDIT AND SECURITY AGREEMENT (this “Agreement”), dated as of September 27, 2019 (the “Closing Date”) by and among MIDCAP FINANCIAL TRUST, a Delaware statutory trust (“MidCap”), as administrative agent, the Lenders listed on the Credit Facility Schedule attached hereto and otherwise party hereto from time to time (each a “Lender”, and collectively the “Lenders”), RIGEL PHARMACEUTICALS, INC., a Delaware corporation (“Rigel”), and the other entities from time to time party to this Agreement as borrowers (collectively in the singular, “Borrower”), provides the terms on which Lenders agree to lend to Borrower and Borrower shall repay the Lenders. The parties agree as follows:
EXHIBIT 10.3 RIGEL PHARMACEUTICALS, INC. 2000 EQUITY INCENTIVE PLAN STOCK OPTION AGREEMENT (INCENTIVE AND NONSTATUTORY STOCK OPTIONS) Pursuant to your Stock Option Grant Notice ("Grant Notice") and this Stock Option Agreement, RIGEL PHARMACEUTICALS,...Rigel Pharmaceuticals Inc • September 15th, 2000 • Services-commercial physical & biological research
RIGEL PHARMACEUTICALS, INC. AND STOCK OPTION AGREEMENT (INCENTIVE AND NONSTATUTORY STOCK OPTIONS)Stock Option Agreement • November 1st, 2011 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Stock Option Agreement, RIGEL PHARMACEUTICALS, INC. (the “Company”) has granted you an option under its 2000 EQUITY INCENTIVE PLAN (the “2000 Plan”) or its 2011 EQUITY INCENTIVE PLAN (the “2011 Plan”), as identified on the Grant Notice (each to be referred to hereinafter, as applicable, as the “Plan”), to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Stock Option Agreement but defined in the Plan shall have the same definitions as in the Plan.
3,650,000 Shares Rigel Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 15th, 2005 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
RIGEL PHARMACEUTICALS, INC. AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 1st, 2011 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • California
THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (“Agreement”) is entered by and between Dr. Donald G. Payan (“Executive”) and RIGEL PHARMACEUTICALS, INC. (the “Company”), a Delaware corporation effective January 1, 2011 (the “Effective Date”). This Agreement shall replace and supersede that certain Employment Agreement between Executive and the Company entered into effective as of December 17, 2007, and amended and restated effective November 13, 2008 (the “Prior Agreement”).
September 26, 2016 Joe Lasaga [Address omitted] Re: Offer and Employment Terms Dear Joe:Release Agreement • November 1st, 2016 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • California
Rigel Pharmaceuticals, Inc. (the Company) is pleased to offer you the position VP, Business Development and Alliance Management, reporting to me, Raul Rodriguez, on the following terms. Please take the next few days to carefully review the terms, and let us know if you have any questions.
RIGEL PHARMACEUTICALS, INC., Issuer AND [·], Trustee INDENTURE Dated as of [·] Debt SecuritiesIndenture • December 14th, 2010 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
THIS INDENTURE, dated as of [·], between RIGEL PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [·], as trustee (the “Trustee”):
13,000,000 Shares Rigel Pharmaceuticals, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • September 17th, 2009 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations • New York
COLLABORATION AGREEMENTCollaboration Agreement • November 14th, 2002 • Rigel Pharmaceuticals Inc • Pharmaceutical preparations
RECITALSCollaborative Research and Development Agreement • September 15th, 2000 • Rigel Pharmaceuticals Inc • Services-commercial physical & biological research • California
